Today in News History
On July 12, several notable moments in the history of News stand out. In 1899, Wilfrid Israel, German businessman and philanthropist (died 1943) was born. In 1953, Suresh Prabhu, Indian accountant and politician, Indian Minister of Railways was born. In 1959, Suzanne Vega, American singer-songwriter, guitarist, and producer was born. In 1968, Michael Geist, Canadian journalist and academic was born. In 1975, Lil' Kim, American rapper and producer was born. In 1980, Tyson Kidd, Canadian wrestler was born. In 1999, Jan Sloot, Dutch computer scientist and electronics technician (born 1945) passed away. In 2004, Renée Saint-Cyr, French actress and producer (born 1904) passed away. In 2008, Michael E. DeBakey, American surgeon and educator (born 1908) passed away. In 2015, André Leysen, Belgian businessman (born 1927) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.
Bio-Techne Corporation (TECH) Merck KGaA - M&A Call - Slideshow
Narrative Intelligence Brief
This article was published by Seeking Alpha, a source frequently categorized with a lean right bias based in United States of America. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of Seeking Alpha, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.
More from Seeking Alpha
July 12, 2026
PepsiCo: It's Undervalued But Recent Growth Struggles Are A Concern
July 12, 2026
Politics And The Markets 07/12/26
July 12, 2026
Wabash National: Stock At A Key Pivot Point During An Industry Recovery
July 12, 2026
Defensive Leader Kraft Heinz Is Experiencing Bullish Capital Rotation
July 12, 2026
RDIV: A Yield Play For A Broader Market, But Not A Buy Yet
Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.More Coverage
Discussion
"cup semifinals"
Julian Alvarez's strike sends defending champion Argentina back to World Cup semifinals
World Cup 2026 Saturday takeaways: Jude Bellingham shines; Argentina takes advantage of Swiss flop
2026 World Cup Semifinal Odds: France, Argentina Favored In Final Four Tilts
How other outlets are covering this story
Compare narratives across 5 related reports from 5 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.
Coverage bias distribution
5 sources
Left 20%
Center 40%
Right 40%
The Eastern Herald
· Jun 26, 2026
Merck KGaA to Pay $11.3 Billion for Bio-Techne in Life Sciences Tools Bet
Germany's Merck KGaA agreed to pay 73 a share in cash for Bio-Techne Corp. TECH, a 36 premium valuing the Minneapolis life sciences tools group at 11.3 billion. The acquisition, the company's biggest since Sigma-Aldrich, gives Merck KGaA a catalog of 425,000 antibodies and emerging spatial biology platforms at the center of drug discovery.
Seeking Alpha
· Jun 26, 2026
Merck KGaA: Bio-Techne Acquisition Improves Quality, But The Stock Seems Fully Valued (Downgrade)
Merck KGaA: Bio-Techne Acquisition Improves Quality, But The Stock Seems Fully Valued (Downgrade)
ArcaMax
· Jun 26, 2026
Bio-Techne will be sold for $11.3B, one of largest deals in Minnesota history
Germany’s Merck KGaA will buy Bio-Techne Corp. in a deal worth 11.3 billion, one of the largest acquisitions in Minnesota history. The sale follows investor pressure on Minneapolis-based Bio-Techne, which makes lab materials and equipment used...
The Motley Fool
· Jul 1, 2026
Revolution Medicines Has a $40 Billion Market Cap and Generates No Revenue. Here's Why That's Not Absurd.
This pre-commercial biotech is worth more than some drugmakers that generate consistent sales.
Men's Health
· Jun 23, 2026
The 30+ Best Amazon Prime Day Tech Sales to Shop Right Now
As selected by our gear, fitness, and tech editors.
Topics:
Related coverage for "Bio-Techne Corporation (TECH) Merck KGaA - M&A Call - Slideshow": The Eastern Herald — Merck KGaA to Pay $11.3 Billion for Bio-Techne in Life Sciences Tools Bet. Seeking Alpha — Merck KGaA: Bio-Techne Acquisition Improves Quality, But The Stock Seems Fully Valued (Downgrade). ArcaMax — Bio-Techne will be sold for $11.3B, one of largest deals in Minnesota history. The Motley Fool — Revolution Medicines Has a $40 Billion Market Cap and Generates No Revenue. Here's Why That's Not Absurd.. Men's Health — The 30+ Best Amazon Prime Day Tech Sales to Shop Right Now